Author： Lorusso Domenica Ferrandina Gabriella Fanfani Francesco Gagliardi Maria Lucia Scambia Giovanni
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.3, 2007-03, pp. : 325-336
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer
Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. :
Belotecan shows promise in both platinum-resistant and -sensitive ovarian cancer
Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. :
By Pectasides Dimitris Psyrri Amanda Pectasides Melina Economopoulos Theofanis
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. :
Targeting Platinum Resistant Disease in Ovarian Cancer
Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. :